...was VP, operations at Catalent Inc. (NYSE:CTLT). The Noven Pharmaceuticals Inc. specialty drug subsidiary of Hisamitsu Pharmaceutical Co. Inc....
...who is resigning. Higo has been Noven’s chairman since 2017 board and has been with Hisamitsu...
...was director of product marketing at Roam Analytics Inc. Jonathan Block, Associate Editor Pfizer Inc. Forma Therapeutics Inc. Beam Therapeutics Hisamitsu Pharmaceutical Co. Inc. Cerebral...

...research. She was interim head of research at the Muscular Dystrophy Association. BioCentury Staff Passage Bio Inc. Novartis AG Hisamitsu Pharmaceutical Co. Inc. Illumina...

...Partners, where he continues as partner emeritus. The Noven Pharmaceuticals Inc. specialty drug subsidiary of Hisamitsu...
...and Hongjiang Li, Staff Writers Alnylam Pharmaceuticals Inc. Atreca Inc. AZTherapies Inc. Eli Lilly and Co. Gilead Sciences Inc. GlaxoSmithKline plc Healx Ltd. Hisamitsu Pharmaceutical Co. Inc. Tizona...

...to week six vs. placebo. Additional data are slated for publication at future scientific meetings. Hisamitsu...
...transdermal patch formulation of the antipsychotic asenapine maleate using Hisamitsu’s Transdermal Drug Delivery System (TDDS). Hisamitsu Pharmaceutical Co. Inc....
...Business: Neurology Molecular target: NA Description: Transdermal patch formulation of the antipsychotic asenapine maleate using Hisamitsu’s...

...cancer pain trial, but did not provide details. HP-3150 is a transdermal patch containing NSAIDs. Hisamitsu Pharmaceutical Co. Inc....
...Treat cancer pain Endpoint: Efficacy; safety Status: Phase III started Milestone: Submit regulatory application (2020) Alicia Parker HP-3150 Hisamitsu Pharmaceutical Co. Inc....

...drug delivery system. Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Product: Emedastine fumarate ( HP-3060 ) Business: Inflammation Julian Zhu HP-3060 Hisamitsu Pharmaceutical Co. Inc. Histamine...

...trial of HP-3150 in patients with cancer pain. The company declined to provide further details. Hisamitsu Pharmaceutical Co. Inc....

...trial to evaluate 2 dose levels of asenapine maleate transdermal patches in about 612 patients. Hisamitsu Pharmaceutical Co. Inc....
...Business: Neurology Molecular target: NA Description: Transdermal tape formulation of the antipsychotic asenapine developed using Hisamitsu’s...

...a placebo-controlled, Japanese Phase II trial to evaluate HP-3150 in patients with lower back pain. Hisamitsu Pharmaceutical Co. Inc....

...began a placebo-controlled, Japanese Phase II/III trial to evaluate HP-3150 in patients with cancer pain. Hisamitsu Pharmaceutical Co. Inc....